Table IV.
Certainty assessment |
Number of patients |
Effect |
Certainty | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Number of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | PRP | No active treatment | Relative (95% CI) | Absolute (95% CI) | |
Pain | |||||||||||
1 | randomised trials | not serious | not serious | not serious | not serious | none | 46 | 49 | - | MD 0.3 VAS lower (7.27 lower to 6.67 higher) | ⊕⊕⊕⊕ High |
Function | |||||||||||
2 | randomised trials | not serious | not serious | not serious | not serious | none | 32 | 32 | - | MD 0.31 VAS higher (0.19 lower to 0.8 higher) | ⊕⊕⊕⊕ High |
PRP, platelet-rich plasma; CI, confidence interval; MD, mean difference; VAS, visual analog scale.